United Kingdom

Juno Therapeutics Inc (JUNO.OQ)

JUNO.OQ on NASDAQ Stock Exchange Global Select Market

16 Jan 2018
Change (% chg)

$-3.15 (-6.46%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Howard Pien

59 2014 Independent Chairman of the Board

Hans Bishop

52 2013 President, Chief Executive Officer, Director

Sunil Agarwal

47 2017 President of Research & Development

Steven Harr

46 2014 Chief Financial Officer, Head of Corporate Development

Hyam Levitsky

54 2015 Executive vice president - Research, chief scientific officer